Submit Deal
All corporates
Similar corporates
HQ - Cambridge
Summary
Bluebird Bio is a biotechnology company that focuses on developing gene therapies for severe genetic diseases and cancer.
Deals Overview
Market Context
Senior Management
Andrew Obenshain
CEO
All Corporates
Back to top
All rights reserved. Copyright © 2025 Datasite
Deals (1)
Service Providers
Relationships
Portfolio
Team
Sort
Target: BLUEBIRD BIO
Bidder: THE CARLYLE GROUP
9 Service Providers
49 Dealmakers
£ 75 M
Value
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy